Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1375.90
1.35 (0.10%) Dr Reddys Laboratories informs about Press Release
Date: 08-04-2015Dr Reddys Laboratories has informed regarding a Press Release dated April 07, 2015 titled 'Dr. Reddys Laboratories and its subsidiary Promius Pharma announce the filing of three NDAs with the USFDA'.
The above information is a part of company’s filings submitted to BSE.